blaVIM-7, an evolutionarily distinct metallo-β-lactamase gene in a Pseudomonas aeruginosa isolate from the United States

被引：115

作者：

Toleman, MA ^{[1
]}

Rolston, K

Jones, RN

Walsh, TR

机构：

[1] Univ Bristol, Dept Pathol & Microbiol, Bristol BS8 1TD, Avon, England

[2] Anderson Med Ctr, Houston, TX USA

[3] JMI Labs, JONES Grp, N Liberty, IA USA

[4] Tufts Univ, Sch Med, Boston, MA 02111 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2004年 / 48卷 / 01期

关键词：

D O I：

10.1128/AAC.48.1.329-332.2004

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

As part of the CANCER Antimicrobial Surveillance Program in North America, a Pseudomonas aeruginosa isolate, strain 07-406, was shown to possess a metallo-beta-lactamase, designated VIM-7. bla(VIM-7) is located on a 24-kb plasmid which can be readily transferred into Enterobacteriaceae and other pseudomonads. This is the first report of a mobile metallo-beta-lactamase gene, bla(VIM-7), being detected within the United States.

引用

页码：329 / 332

页数：4

共 15 条

[1] INVITRO EVALUATION OF BRL 42715, A NOVEL BETA-LACTAMASE INHIBITOR [J].

COLEMAN, K ;

GRIFFIN, DRJ ;

PAGE, JWJ ;

UPSHON, PA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (09) :1580-1587

[2] Antibiotic resistance in gram-negative bacteria: the role of gene cassettes and integrons [J].

Hall, RM ;

Collis, CM .

DRUG RESISTANCE UPDATES, 1998, 1 (02) :109-119

[3] Structure of In31, a blaIMP-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes [J].

Laraki, N ;

Galleni, M ;

Thamm, I ;

Riccio, ML ;

Amicosante, G ;

Frère, JM ;

Rossolini, GM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) :890-901

[4] Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate [J].

Lauretti, L ;

Riccio, ML ;

Mazzariol, A ;

Cornaglia, G ;

Amicosante, G ;

Fontana, R ;

Rossolini, GM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) :1584-1590

[5] Carbapenem-hydrolysing VIM-2 metallo-β-lactamase in Pseudomonas aeruginosa from Greece [J].

Mavroidi, A ;

Tsakris, A ;

Tzelepi, E ;

Pournaras, S ;

Loukova, V ;

Tzouvelekis, LS .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) :1041-1043

[6] Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-β-lactamase VIM-1 [J].

Miriagou, V ;

Tzelepi, E ;

Gianneli, D ;

Tzouvelekis, LS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) :395-397

[7] Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France [J].

Poirel, L ;

Naas, T ;

Nicolas, D ;

Collet, L ;

Bellais, S ;

Cavallo, JD ;

Nordmann, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) :891-897

[8] Novel variant (blaVlM-4) of the metallo-β-lactamase gene blaVIM-1 in a clinical strain of Pseudomonas aeruginosa [J].

Pournaras, S ;

Tsakris, A ;

Maniati, M ;

Tzouvelekis, LS ;

Maniatis, AN .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (12) :4026-4028

[9] Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America:: report from the SENTRY antimicrobial surveillance programme [J].

Toleman, MA ;

Simm, AM ;

Murphy, TA ;

Gales, AC ;

Biedenbach, DJ ;

Jones, RN ;

Walsh, TR .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (05) :673-679

[10] Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece [J].

Tsakris, A ;

Pournaras, S ;

Woodford, N ;

Palepou, AFI ;

Babini, GS ;

Douboyas, J ;

Livermore, DM .

JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (03) :1290-1292

← 1 2 →